Paradigm Medical Industries, Inc. (PDMI)
- Previous Close
0.0002 - Open
0.0002 - Bid --
- Ask --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.0002 - Volume
100 - Avg. Volume
0 - Market Cap (intraday)
1.3M - Beta (5Y Monthly) -0.98
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.
www.paradigm-medical.comRelated News
Performance Overview: PDMI
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PDMI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PDMI
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
-2.00
Financial Highlights
Profitability and Income Statement
Profit Margin
-45.58%
Return on Assets (ttm)
-13.73%
Return on Equity (ttm)
--
Revenue (ttm)
757k
Net Income Avi to Common (ttm)
-345k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
21k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
229.88k
Company Insights: PDMI
PDMI does not have Company Insights